{
    "nctId": "NCT00954564",
    "briefTitle": "Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase Inhibitors",
    "officialTitle": "Arthralgia and Medication Adherence in Women With Early Stage Breast Cancer Taking Aromatase Inhibitors: The Breast Cancer Adjuvant Therapy (BCAT) Longitudinal Cohort Study.",
    "overallStatus": "COMPLETED",
    "conditions": "Arthralgia, Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 351,
    "primaryOutcomeMeasure": "Arthralgia incidence, defined as proportion of the baseline population (those who have taken \u2265 9 doses of aromatase inhibitor [AI]) in which new or worsening joint pain or stiffness is observed at 1, 3, and 12 months after beginning AI therapy",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Planning to begin aromatase inhibitor (AI) therapy or taken fewer than 10 doses of adjuvant AI therapy\n* Hormone-receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Postmenopausal\n* ECOG performance status 0-1\n* Able to understand and respond to questions in English\n* No condition that would impair the ability to provide informed consent\n* No other non-breast cancer condition\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics\n* No more than 9 prior doses of AI",
    "sex": "FEMALE",
    "minimumAge": "35 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}